Absci (ABSI) Current Leases (2020 - 2026)
Absci (ABSI) posted Current Leases of $1.9 million for Q1 2026, up 2.88% sequentially from $1.8 million in Q4 2025, and up 12.14% YoY from $1.7 million in Q1 2025.
Absci (ABSI) Current Leases (2020 - 2026) Analysis & Trends
Absci has reported Current Leases for 7 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Current Leases rose 12.14% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 12.14% YoY) and the FY2025 annual result came in at $1.8 million, up 12.25% from the prior year.
- Current Leases rose to $1.9 million in Q1 2026 per ABSI's latest filing, from $1.8 million in the prior quarter.
- Over five years, Current Leases peaked at $2.8 million in Q1 2022 and troughed at $2000.0 in Q3 2025.
- A 5-year average of $1.6 million and a median of $1.7 million in 2025 frame the typical range for Current Leases.
- The widest YoY moves for Current Leases: up 682.11% in 2025, down 99.87% in 2025.
- Over 5 years, Current Leases stood at $2.3 million in 2022, then retreated by 26.87% to $1.7 million in 2023, then fell by 4.23% to $1.6 million in 2024, then grew by 12.25% to $1.8 million in 2025, then increased by 2.88% to $1.9 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.9 million, $1.8 million, and $2000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Absci | 1.58 Bn | 1.37 Bn | - | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.04 Mn |
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Sep 30, 2021 | 1.46 Mn |